Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioAtla, Inc.

0.3700
+0.01504.23%
Volume:269.39K
Turnover:97.62K
Market Cap:21.47M
PE:-0.22
High:0.3750
Open:0.3541
Low:0.3500
Close:0.3550
Loading ...

BioAtla Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

HC Wainwright Downgrades BioAtla to Neutral From Buy

MT Newswires Live
·
13 Nov 2024

Bioatla Inc : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
13 Nov 2024

BioAtla: Strong Financials and Promising Clinical Progress Drive Buy Rating

TIPRANKS
·
13 Nov 2024

BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

GuruFocus.com
·
09 Nov 2024

Bioatla Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

BioAtla Q3 2024 GAAP EPS $(0.22) Beats $(0.39) Estimate, Sales $11.000M

Benzinga
·
08 Nov 2024

BioAtla GAAP EPS of -$0.22 beats by $0.15, revenue of $11M

seekingalpha
·
08 Nov 2024

BRIEF-BioAtla Q3 Net Income USD -10.586 Million

Reuters
·
08 Nov 2024

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

GlobeNewswire
·
08 Nov 2024

Bioatla Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024

GlobeNewswire
·
31 Oct 2024

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025

Insider Monkey
·
21 Oct 2024

BioAtla Inc (BCAB) Q2 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

GuruFocus.com
·
10 Oct 2024

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire
·
04 Oct 2024

Pleasing Signs As A Number Of Insiders Buy BioAtla Stock

Simply Wall St.
·
03 Oct 2024